Société HedgePath Pharmaceuticals Inc
Actions
US42278K1025
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Niraj Vasisht
BRD | Director/Board Member | 61 | 13/12/22 |
Michelle Yanez
BRD | Director/Board Member | 52 | 13/12/22 |
Michael Jerman
BRD | Director/Board Member | 40 | 24/05/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 172 023 545 | 71 400 692 ( 41,51 %) | 0 | 41,51 % |
Coordonnées société
Inhibitor Therapeutics, Inc.
449 South 12th Street Unit 1705
33602, Tampa
+813 864 2562
http://www.inhibitortx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+17,76% | 47,02 Md | |
+48,77% | 41,86 Md | |
+0,96% | 41,76 Md | |
-4,27% | 28,8 Md | |
+11,58% | 26,05 Md | |
-21,24% | 19,15 Md | |
+4,25% | 12,55 Md | |
+28,51% | 12,34 Md | |
-4,40% | 11,82 Md |